Author

Serena Zambarbieri

Institute of Oncology Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:long-read sequencing· 1

Frequent Co-Authors

Alberto J. ArribasiD· 1 shared Alex ZadroiD· 1 shared Andrea RinaldiiD· 1 shared Chiara TarantelliiD· 1 shared Filippo SprianoiD· 1 shared Francesca GuidettiiD· 1 shared Francesco BertoniiD· 1 shared Luciano CascioneiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto J. ArribasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancer lncRNA LOC730338 modulates BCR signaling and immune evasion in lymphoma by regulating RNA homeostasis.

Luciano Cascione, Francesca Guidetti, Sunandini Ramnarayanan, Andrea Rinaldi, Filippo Spriano, Alex Zadro, Chiara Tarantelli, Serena Zambarbieri, Nicolas Munz, Simone Avesani, Alberto J. Arribas, Rosalba Giugno, Rory Johnson, Francesco Bertoni, Sara Napoli

This paper identifies ADARreg, an elncRNA that modulates BCR signaling and immune evasion in lymphoma by altering RNA stability, localization, and editing, providing a potential therapeutic target.

bioRxiv · Dec 10, 2024 · PreprintCancer Biology